Asset Dedication LLC Sells 1,619 Shares of UnitedHealth Group Incorporated $UNH

Asset Dedication LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 15.0% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 9,139 shares of the healthcare conglomerate’s stock after selling 1,619 shares during the quarter. Asset Dedication LLC’s holdings in UnitedHealth Group were worth $2,851,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of UNH. Forefront Analytics LLC grew its stake in shares of UnitedHealth Group by 4.2% during the 1st quarter. Forefront Analytics LLC now owns 820 shares of the healthcare conglomerate’s stock valued at $430,000 after acquiring an additional 33 shares during the period. TFB Advisors LLC raised its position in shares of UnitedHealth Group by 2.7% during the 1st quarter. TFB Advisors LLC now owns 1,272 shares of the healthcare conglomerate’s stock valued at $666,000 after purchasing an additional 33 shares during the period. Bank OZK raised its holdings in UnitedHealth Group by 4.6% during the first quarter. Bank OZK now owns 766 shares of the healthcare conglomerate’s stock valued at $401,000 after acquiring an additional 34 shares during the period. GK Wealth Management LLC grew its position in shares of UnitedHealth Group by 7.2% during the first quarter. GK Wealth Management LLC now owns 506 shares of the healthcare conglomerate’s stock worth $265,000 after purchasing an additional 34 shares in the last quarter. Finally, Western Pacific Wealth Management LP boosted its stake in UnitedHealth Group by 12.0% in the 2nd quarter. Western Pacific Wealth Management LP now owns 336 shares of the healthcare conglomerate’s stock worth $105,000 after purchasing an additional 36 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $341.83 on Friday. The firm has a market capitalization of $309.65 billion, a price-to-earnings ratio of 17.84, a PEG ratio of 2.23 and a beta of 0.43. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.82 and a current ratio of 0.82. The stock’s 50-day simple moving average is $339.84 and its 200-day simple moving average is $317.07. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $606.36.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping the consensus estimate of $2.87 by $0.05. The company had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. UnitedHealth Group’s revenue was up 12.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $7.15 EPS. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be paid a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 46.14%.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on UNH. Piper Sandler cut their price objective on UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a research report on Tuesday, October 28th. KeyCorp lifted their price target on UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. Leerink Partners set a $410.00 target price on shares of UnitedHealth Group and gave the company an “outperform” rating in a research note on Wednesday, October 29th. Zacks Research upgraded UnitedHealth Group from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Finally, UBS Group lifted their price target on shares of UnitedHealth Group from $378.00 to $430.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th. Seventeen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $385.54.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.